News Conference News ESC 2025 MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide Caitlin E. Cox August 30, 2025
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ESC 2020 EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class Michael O'Riordan August 29, 2020
News Daily News Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Shelley Wood May 11, 2020
News Daily News Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR Yael L. Maxwell July 11, 2019
News Daily News MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes Shelley Wood June 14, 2016